HighMark Wealth Management’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
– Sell
-438
Closed -$60K – 497
2020
Q3
$60K Buy
438
+392
+852% +$41.7K 0.05% 94
2020
Q2
$53K Buy
+46
New +$3.84K 0.06% 78

HighMark Wealth Management's MYOK Position: Q4 2020 in Review

HighMark Wealth Management sold out of MyoKardia, Inc. Common Stock (MYOK) in Q4 2020, closing a stake of 438 shares — an estimated $60K sold.

HighMark Wealth Management first reported a position in MYOK in Q2 2020 and held it in 2 quarters. The position peaked at $60K in Q3 2020. 0 funds tracked by Wall St. Rank hold MYOK as of Q4 2020.

  • HighMark Wealth Management reported no remaining MyoKardia, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
  • HighMark Wealth Management sold 438 MyoKardia, Inc. Common Stock shares in Q4 2020, an estimated $60K.
  • HighMark Wealth Management first reported a position in MyoKardia, Inc. Common Stock in Q2 2020 and held it in 2 quarters.
  • HighMark Wealth Management's MyoKardia, Inc. Common Stock position peaked at $60K in Q3 2020.
  • 0 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q4 2020.

Based on HighMark Wealth Management's 13F filing for Q4 2020, filed 27 Jan 2021.